cation channel abundantly expressed in the heart, has been implicated in conduction block and other arrhythmic propensities associated with cardiac remodelling and injury. The present study aimed to quantitatively evaluate the arrhythmogenic potential of TRPM4. 
Methods and results
Patch clamp and biochemical analyses were performed using expression system and an immortalized atrial cardiomyocyte cell line (HL-1), and numerical model simulation was employed. After rapid desensitization, robust reactivation of TRPM4 channels required high micromolar concentrations of Ca 2þ . However, upon evaluation with a newly devised, ionomycin-permeabilized cell-attached (Iono-C/A) recording technique, submicromolar concentrations of Ca 2þ (apparent K d = $500 nM) were enough to activate this channel. Similar submicromolar Ca 2þ dependency was also observed with sharp electrode whole-cell recording and in experiments coexpressing TRPM4 and L-type voltage-dependent Ca 2þ channels. Numerical simulations using a number of action potential (AP) models (HL-1, Nygren, Luo-Rudy) incorporating the Ca 2þ -and voltage-dependent gating parameters of TRPM4, as assessed by Iono-C/A recording, indicated that a few-fold increase in TRPM4 activity is sufficient to delay late AP repolarization and further increases (> _ six-fold) evoke early afterdepolarization. These model predictions are consistent with electrophysiological data from angiotensin II-treated HL-1 cells in which TRPM4 expression and activity were enhanced. 
.. Conclusions
These results collectively indicate that the TRPM4 channel is activated by a physiological range of Ca 2þ concentrations and its excessive activity can cause arrhythmic changes. Moreover, these results demonstrate potential utility of the first AP models incorporating TRPM4 gating for in silico assessment of arrhythmogenicity in remodelling cardiac tissue.
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Introduction
Cardiac arrhythmia is a major global cause of mortality and morbidity, especially in developed countries. Its underlying mechanisms involve both congenital and acquired factors, with the latter being more predominant and often associated with pathologic remodelling of the heart. such as chronic hypertension, diabetes mellitus, chronic heart failure, and ischaemic myocardial diseases. Compelling evidence supports the involvement of several transient receptor potential (TRP) proteins in the initiation and progression of cardiac remodelling. For instance, several different lines of evidence yielded from transgenic mouse approaches suggest a tight connection between TRPC1, TRPC3, TRPC4, TRPC6, and TRPV2 channels, and cardiac hypertrophy and cardiomyopathy. 2, 3 TRP channels, which contain six transmembrane segments, comprise a large Ca 2þ -permeable cation channel superfamily expressed throughout the whole body that are activated by a broad spectrum of physicochemical stimuli from cellular microenvironments such as neurohormonal, thermal and mechanical stresses, as well as by synthetic and naturally occurring chemicals. These properties render TRP channels plausible regulators/ mediators for many biological functions and dysfunctions through altered cellular Ca 2þ homeostasis and dynamics. 4 Recently, several lines of evidence have implicated melastatin TRP subfamily member TRPM4 in cardiac arrhythmogenicity. TRPM4 is relatively abundantly expressed in the cardiac conduction system and atrial tissues. Gain-of-function mutations in N-terminal and intracellular loop domains identified in a few pedigrees of French and Lebanese families manifested as progressive conduction blocks and associated sudden death, and reportedly produced degenerative changes of cardiac Purkinje fibres. 5 In fact, significant contribution of TRPM4-mediated current has been demonstrated during the repolarization phase of rabbit Purkinje fibre action potentials. 6 In spontaneously hypertensive rats (SHRs), long-term pressure overload produces hypertrophic changes in the heart that are accompanied by upregulation of TRPM4 protein and its excessive activity. These changes are associated with prolongation of QT interval in electrocardiograms, a risk factor of arrhythmia. 7 In murine hearts exposed to acute anoxic insults, early afterdepolarization (EAD)-like oscillations occurred in the repolarization phase of action potentials (APs), which were inhibited by the TRPM4 channel blocker 9-phenathrol (9-PA). 8 The same drug was also shown to mitigate experimental myocardial infarction, 9 accelerate atrial AP repolarization, 10 and decelerate spontaneous atrial AP firing governed by the sinoatrial nodal rhythm.
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Finally, knock-out of trpm4 gene in mice was found to accelerate AP repolarization with enhanced b-adrenergic inotropic response in ventricular muscle, 12 and cause pleiotropic arrhythmic changes characterized by prolonged PR and QRS intervals and multi-level conduction blocks. 13 Collectively, these observations support significant contribu- 
Immunoblotting
TRPM4, brain natriuretic peptide (BNP), and b-actin proteins were extracted from HL-1 cells, electrophoresed, incubated with their respective antibodies, and visualized by a horseradish peroxidase-based immunoblotting method. 
Numerical model simulation

Solutions
Solutions used for patch clamping and Ca 2þ imaging were essentially the same as previously described. 18 
Statistical evaluation
All data are expressed as mean ± standard error of the mean. Statistical significance (P < 0.05) was evaluated by Student's t-test or analysis of variance (ANOVA) with either Tukey's or Dunnett's post-hoc tests for single and multiple comparisons, respectively.
In Supplementary material online, animal experiments followed the NIH Guide for the Care and Use of Laboratory Animals and were approved by the local bioethics committee of Fukuoka University. Mice were anaesthetized by intraperitoneal injection of pentobarbital (60 mg/ kg) with 0.1 mL heparin (1000 IU/mL), and exsanguinated by carefully excising the whole heart. Figure S1 ) or 5lM dioctanoylglycerol-phosphatidylinositol 4,5-bisphosphate (diC8-PIP 2 ; data not shown). 15 One known approach to alleviate the rundown of membrane current is a cell-membrane permeabilization technique incorporating small pore-forming agents such as b-escin. 19 However, this agent only partially restored TRPM4 channel activity (see Supplementary material online, Figure S2 ). 20 We improved this method so as to rapidly activate TRPM4 channels by use of a custom-made fast solution-exchange device comprised of electrically-driven solenoid valves. As illustrated and demonstrated in Figures 1A and B, respectively, after 'giga' seal formation (i.e. cell-attached conditions), the cell was quickly exposed to ionomycin (2. Figure 1E ). Figure 1E shows the relationship between normalized I TRPM4 amplitude and [Ca 2þ ] i . Although some inaccuracy is inevitable because of separate measurements, the relationship yields a submicromolar K d concentration (0.51 lM; Figure 1E ). To corroborate the submicromolar K d value estimated by Iono-C/A recording, we next recorded macroscopic I TRPM4 by directly dialysing various [Ca 2þ ] i into the cell. To minimize the severe rundown of I TRPM4
resulting from washout, we adopted sharp patch electrodes with a high input resistance (8-10 MX). Almost immediately after commencing whole-cell conditions ('break-in'), noticeable inward currents with a clear outward-rectifying property developed (Figures 2A-D and F).
Magnitudes and time courses of these currents were dependent on [Ca 2þ ] i in the patch pipette with an apparent activation threshold lower than 0.3 lM, which was essentially unchanged in the presence of a fast Ca 2þ chelator (BAPTA; Figure 2D ) or even after 10 lM ryanodine and caffeine was applied to deplete internal Ca 2þ stores ( Figure 2E ). K d values estimated under these conditions (0.6-0.7 lM; Figure 2D ) were similar to those estimated by Iono-C/A recording. In another attempt to validate the submicromolar Ca 2þ -sensitivity of I TRPM4 , we coexpressed L-type (VDCCs) with TRPM4 channels and investigated the relationship between Ca 2þ influx through the former and the extent of activation of the latter. As shown in Figure 3A , large tail currents (I tail ) at -60 mV (indicated by arrows) appeared just following the Ca 2þ influxes through VDCC. I tail was completely abolished in Na þ -free external solution ( Figure 3B and open diamonds in Figure 3D ) and strongly inhibited by 10 lM 9-PA, which is a relatively selective inhibitor of TRPM4 21 ( Figure 3C and filled circles in Figure 3D ). These observations strongly indicate that I tail resulted from the activation of TRPM4 channels by the preceding Ca 2þ influx. The magnitude of I tail was dependent on the total Ca 2þ charge carried through VDCC (i.e. integral of Ca 2þ influx:
Q Ca , dashed curve in Figure 3D ). Figure 3E shows the relationship between Q Ca and I tail amplitude normalized to its maximum and cell capacitance, which yielded a half-activation Ca 2þ charge (Q Ca,0.5 ) of In aggregate, these three different lines of evidence strongly suggest that TRPM4 channels can be activated at physiologically attainable [Ca 2þ ] i and membrane potential.
TRPM4 upregulation alters AP characteristics in angiotensin II-treated HL-1 cells
To explore the significance of TRPM4 activation in a more physiological context, we next employed an immortalized mouse atrial cardiomyocyte line HL-1. 16 To evaluate the density of functional TRPM4 channels in these cells, we adopted an inside-out (I/O) configuration rather than whole-cell, as intracellular perfusion of Ca 2þ caused irreversible contractions of HL-1 myocytes. As demonstrated in Figures 4A and B, single cation channel activities induced by 100 lM Ca 2þ were inhibited by 9-PA in a concentrationdependent manner and exhibited a similar inhibitory potency for expressed TRPM4 channels (see Supplementary material online, Figure  S1E ). Furthermore, the unitary conductance (24.5 ± 2.1 pS, n = 5), reversal potential (-4.1 ± 1.7 mV, n = 5) and outward-rectifying property of these channels ( Figure 4C ) were similar to those of expressed TRPM4 channels. Expression of TRPM4-immunoreactive protein was significantly increased after 4-day treatment of HL-1 cells with 1 lM angiotensin II (AGII). This occurred in parallel with the upregulation of the cardiac remodelling marker BNP ( Figure 4F) . Concomitantly, the maximum density of TRPM4-like channel activities (at 1000 lM [Ca 2þ ] i ) increased more than five-fold ( Figures 4D, E , and G). These results strongly suggest that prolonged neurohormonal stress would dramatically upregulate functional TRPM4 activities in HL-1 cells. It is well known that electrical remodelling of cardiomyocytes significantly affects the shape of action potentials (APs), thereby increasing arrhythmic propensity. 22 Therefore, we tested whether AGII treatment threshold for injected outward currents to evoke APs, and shortening of APD particularly at the late repolarization phase ( Figures 4H and I) . Changes in AP morphology by 9-PA may occur through its nonspecific action on other types of channels than TRPM4. To exclude this possibility and investigate the effects of AGII treatment more systematically, we next adopted an siRNA knockdown strategy. As summarized in Figure 5 , siRNA-induced downregulation of TRPM4 expression and activity significantly abrogated AP prolongation (APD 90 but not APD 50 ) and RMP depolarization induced by AGII treatment. Consequently, the inhibitory effects of 9-PA (10 lM) were greatly reduced ( Figure 5D-G) .
These results collectively suggest that remodelling stress, such as that induced by AGII treatment, significantly alters the RMP and AP characteristics of HL-1 cells through TRPM4 upregulation.
Quantitative description of TRPM4 gating kinetics
The hitherto-mentioned results strongly support the idea that upregulation of TRPM4 channel activity contributes to the electrical remodelling of HL-1 cells. To quantify this property, we next evaluated the gating kinetics of TRPM4 channels with respect to [Ca 2þ ] i and membrane potential by Iono-C/A recording. Figure 6 shows a representative experiment. To avoid the influence of rundown/desensitization, the Iono-C/A recording protocol ( Figure 1 ) was further modified to reduce time of Ca 2þ exposure to as short as possible (see Figure 6A and its legend).
Figures 6B and C show overlaid traces of I TRPM4 during and immediately after voltage step pulses at low (0.3 mM) and very high (5 mM) [Ca 2þ ] o , respectively. Each current trace is fitted to a monoexponential time course (red). The voltage-dependency of I TRPM4 at the beginning and end of pulses evaluated in this way are almost linear and outward-rectifying, respectively ( Figure 6D ). Steady state activation curves of the TRPM4 channel ( Figure 6E ) assessed from tail current amplitudes (immediately after pulses; Figure 6C) online, Figure S3 ). voltage-dependent gating processes occur in a serial fashion, 23 and instead suggests that channel gating is allosterically controlled. 24 We, therefore, adopted an empirical Hodgkin-Huxley-type formalism to approximate TRPM4 channel gating with a simple two-state transition model with rate constants (a and b) described as functions of both V m and Ca 2þ ( Figures 7C-F 
Numerical AP models reproduce TRPM4-mediated changes in HL-1 cells
We incorporated the rate constants described above into a recently developed HL-1 AP model 17 and two other representative AP models for atrial and ventricular cardiomyocytes, i.e. Nygren 1998 and Luo-Rudy 2000 models, respectively, (Supplementary Material Information). A few-fold increase in TRPM4 current density is sufficient to produce significant depolarization of RMP and prolongation of APD in both HL-1 and Nygren atrial models (Figures 7Gb and H) , and the degree of AP prolongation in the HL-1 model is comparable to that estimated in AGII-treated HL-1 cells as the 9-PA sensitive component ( Figures 4I and  5D) . A similar extent of AP prolongation was also simulated in the Luo-Rudy ventricular model with increased TRPM4 density ( Figure 7I) . Intriguingly, further increase in TRPM4 current density (> _ six-fold) induces early afterdepolarizations (EADs) superimposed on the late repolarization phase in both HL-1 and Luo-Rudy models (Figures 7Gb  right and I) , and these premature depolarizations were also occasionally recorded from AGII-treated HL-1 cells (Figures 7Ga) . In addition, although TRPM4 channel density remains unknown, significant AP prolongation is simulated by incorporating TRPM4 gating kinetics into the Aslanidi Purkinje fibre model ( Figure 7J) .
Collectively, these results strongly suggest that the mathematical expressions of TRPM4 gating described above are instrumental for predicting the electrophysiological changes induced in remodelled cardiomyocytes in silico.
Discussion
Although several animal studies implicate TRPM4 in biological functions and dysfunctions, 4 ] i during membrane excitation and receptor stimulation, it is tenable to assume significant contributions of TRPM4 to a broad spectrum of cellular physiology and pathophysiology. Indeed, our numerical model, which for the first time formulates TRPM4 channel gating (Figures 7Gb and H) , has successfully simulated the observed AP changes in a cardiomyocyte cell line HL-1 ( Figures 4I and 5D) . Furthermore, simulations using the same TRPM4 parameters in a few other AP models (Luo-Rudy and Aslanidi; Figure 7 ) point to the possibility that upregulation of TRPM4 activity may be a key predisposing factor for arrhythmia.
Relevance of the use of ionomycin for kinetic evaluation
Through the present investigation, we have found that a combination of cell-attached recording and ionomycin-mediated membrane online, Figure S3A ), thereby enabling detailed investigation of the Ca 2þ -dependent kinetics of TRPM4 channel over a wide range of membrane potentials ( Figure 6 ). This method is advantageous compared with conventional whole-cell or inside-out single channel recordings in which severe rundown/desensitization of TRPM4 channel activity inevitably occurs. Staphyloccocal toxin is another potentially useful agent to minimize rundown, but a previous study reported that this toxin was ineffective at mitigating the extent of TRPM4 desensitization. 25 As ionomycin is known to liberate Ca 2þ from internal stores, 26 we eliminated this undesirable effect by applying ionomycin in Ca 2þ -free solution once and then repeatedly rinsing the cell with Ca 2þ -free solution before the next application of Ca 2þ , which prevented the replenishment of Ca 2þ stores (see Supplementary material online, Figure S3B ).
These findings strongly support the technical advantages of Iono-C/A recording to evaluate TRPM4 channel gating kinetics. In principle, this method could be more broadly applied to other TRP family members that undergo similar irreversible rundown/desensitization.
Upregulation of TRPM4 accounts for altered AP morphology
HL-1, an immortalized cell line derived from an atrial tumor, 16 retains many features reminiscent of cardiomyocytes, such as spontaneous APs and contractions with expression of ion channels responsible for AP generation, e.g. voltage-dependent Na þ , Ca 2þ , and K þ channels. 27, 28 We confirmed the emergence of these channels together with TRPM4 channels in beating HL-1 cells (data not shown), which generated typical atrial-type APs of triangular morphology (Figures 4 and 5) . Although data interpretation is limited by substantial differences in electrophysiological details between HL-1 cells and freshly dissociated atrial cardiomyocytes, use of the former is advantageous for precisely fitting numerical model parameters to experimental results, as it is technically easy to manipulate the expression level of given channels in HL-1 cells by means of siRNA or gene delivery in a time-matched manner under well-controlled conditions. Importantly, the expression and activity of TRPM-like channels were enhanced several-fold (on average four-to five-fold) by AGII, which caused prominent AP prolongation at the late repolarization phase (APD 90 ), a positive shift of RMP ( Figure 5) , and, in some other cases, EAD-like depolarizations ( Figure 7Ga ). All these changes were specifically abolished by siRNA knockdown of TRPM4, as well as by 9-PA at a concentration of 10 lM, which almost selectively inhibited TRPM4 channels (see Supplementary material online, Figure S4A and B). 6, 8, 21 Although 9-PA reportedly inhibits Ca 2þ -activated Cl -channels, 29 such nonspecific actions can largely be excluded because benzbromarone (10 lM), an antagonist of TMEM16A (molecular identity of the Cl -channel), is unable to inhibit APs in HL-1 cells (see Supplementary material online, Figure S4C ).
The most straightforward interpretation of these results is that cardiac remodelling upregulates TRPM4 expression, thereby prolonging AP to raise arrhythmogenicity. Indeed, our preliminary experiments with atrial myocytes from AGII-treated mouse hearts confirm that even moderate upregulation of TRPM4 (about three-fold) can cause significant AP prolongation (see Supplementary material online, Figure S5 ), the extent of which is comparable to results simulated with the Nygren model ( Figure 7H) . Moreover, a query of the Gene Expression Omnibus (GEO) microarray database indicated significantly higher cardiac trpm4 mRNA expression in individuals with high-risk for arrhythmia, such as patients with idiopathic dilated and ischaemic heart failures, compared with normal controls (P < 0.05 with Wilcoxon/Kruskal-Wallis test). Although values were scattered (probably because of complex etiologies), expression levels of trpm4 mRNA in these patients were much higher (up to $nine-fold) than in the majority of normal individuals (GEO Profiles Database: GDS651/219360_s_at). These findings support the view that pathological upregulation of TRPM4 activity may increase the arrhythmic propensity of cardiac tissue. However, during chronic atrial fibrillation, shortened APD increases the risk of reentrant arrhythmias through a reduced refractory period. 22 In guinea-pig atrial muscle, short-term application of AGII reportedly facilitated reentry via accelerated AP repolarization by enhancing slow delayed rectifier K þ channel activity. 30 Presumably, this discrepancy reflects the complexities of electrical and structural reorganization of the heart. Thus, for its clarification, precise evaluation of TRPM4 activation profiles in the context of both AP generation and propagation is required, the properties of which change during cardiac remodelling. 22 Finally, in normal mouse ventricular muscle, a negative impact of TRPM4 channel activity on cardiac contractility despite AP prolongation has been proposed. This likely occurs through membrane depolarization resulting from TRPM4 channel activation, which in turn decreases voltagedependent Ca 2þ influx during the AP as the result of a reduced Ca 2þ driving force. This mechanism was found suppressed in TRPM4-knock-out mice. 12 Moreover, genetic deletion of trpm4 in mouse has been shown to prolong PR and QRS intervals, and cause multi-level conduction blocks, 13 whereas human gain-of-function mutations of TRPM4 (e.g. E7K) also cause conduction blocks. 5 Such variable and complex consequences resulting from genetic manipulation of TRPM4 in animals, even though they can directly address the physiological/pathophysiological consequences, would reflect the influence of long-term constitutive gene suppression that inevitably accompany compensatory changes, thus possibly giving a different picture from human pathophysiology. In this regard, the theoretical approaches adopted in the present study may serve as a complementary strategy to provide testable predictions for animal experiments, facilitating comprehensive deciphering of the complexity of the dynamical system(s) in which TRPM4 channels operate. The present approach using acute knockdown of TRPM4 by siRNA strategy also brings additional insight to the findings obtained by constitutive knock-out of this gene in mice. Figures 7A and B) . This indicates the practical utility of these mathematical expressions in the physiological range of [Ca 2þ ] i and membrane potential.
Our simulations with HL-1 17 and Nygren models indicated that although little change could be observed at normal density, a moderate (three-to five-fold) increase in TRPM4 activity is sufficient to cause significant AP prolongation. This prediction is consistent with observations in AGII-treated HL-1 cells. In addition, the HL-1 model also predicted that when the degree of TRPM4 activity increase is more prominent (> _ six-fold), a more striking change, i.e. EAD, can occur. This was indeed observed in some AGII-treated HL-1 cells that showed EAD-like premature depolarizations. A similar EAD-like excitation resulting from a high degree of TRPM4 upregulation (> _six-fold) was simulated by the Luo-Rudy model incorporating TRPM4 gating kinetics ( Figure 7I ). It is noteworthy that in SHRs, which undergo sustained pressure overload from hypertension, TRPM4 expression was profoundly increased with significant QT elongation observed in electrocardiograms. 7 It is intriguing to note that an early version of the Luo-Rudy model already demonstrated significant contribution of Ca 2þ -activated nonselective cation channels (NSC Ca ) to the genesis of EADs and delayed afterdepolarizations (DAD). 31 However, the primary difference between this study and ours lies in that the former defines NSC Ca conductance as an immediately equilibrated reaction with Ca 2þ , thus ignoring its strong voltage-dependent gating. Hence, simulated membrane responses resulting from NSC Ca activation simply mirror [Ca 2þ ] i change, and tend to overestimate activation of NSC Ca around RMP, but underestimate it at more depolarized potentials. In sharp contrast with this, our formulation of TRPM4 channel gating more precisely describes its timedependent activation by both [Ca 2þ ] i and membrane potential. As shown in Supplementary material online, Figure 6D , incorporating this property strongly blunts the activation of TRPM4 near RMP compared with more depolarized potentials. Thus, voltage-dependent gating may render TRPM4 channels more contributive to AP prolongation than abnormal diastolic depolarizations, which occur after complete termination of AP. These simulated results would not favor the involvement of NSC Ca or TRPM4 channels in DAD. 32 In summary, the present study has proven, under minimally celldisturbing conditions, that the TRPM4 channel is activated by a physiological range of [Ca 2þ ] i , and provided the first mathematical formulation of its Ca 2þ -and voltage-dependent gating. Further, numerical simulations with several AP models incorporating TRPM4 gating kinetics have suggested that excessive activity of TRPM4 can cause arrhythmic changes. When combined with animal experiments, further improvements of this theoretical approach (not only as AP models, but twodimensional sheet and whole-heart models) may help to understand more complex, multi-hierarchical mechanisms underlying some reentrant arrhythmias and conduction failures associated with genetic mutations of the TRPM4 channel. 
